We are live on ! Find out more
JMFC

J.M. Forbes & Co Portfolio holdings

AUM $1.27B
1-Year Est. Return 26.46%
This Fund
S&P 500
This Quarter Est. Return
-5.06%
1 Year Est. Return
+26.46%
3 Year Est. Return
+95.08%
5 Year Est. Return
+123.89%
10 Year Est. Return
+430.29%
AUM
$351M
AUM Growth
-$20M
Cap. Flow
+$644K
Cap. Flow %
0.18%
Top 10 Hldgs %
33.23%
Holding
107
New
3
Increased
33
Reduced
25
Closed
6

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$3.1M
2
NVS icon
Novartis
NVS
+$2.81M
3
CSCO icon
Cisco
CSCO
+$231K
4
MSFT icon
Microsoft
MSFT
+$214K
5
PG icon
Procter & Gamble
PG
+$204K

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$3.1M
2
MRK icon
Merck
MRK
+$2.21M
3
GE icon
GE Aerospace
GE
+$245K
4
COP icon
ConocoPhillips
COP
+$237K
5
MON
Monsanto Co
MON
+$236K

Sector Composition

Rank Sector Weight
1 Technology 18.68%
2 Healthcare 15.51%
3 Financials 12.19%
4 Consumer Staples 10.32%
5 Industrials 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTSH icon
26
Cognizant
CTSH
$22.3B
$6.59M 1.88%
105,282
+201
+0.2% +$12.6K
PNC icon
27
PNC Financial Services
PNC
$99.6B
$6.54M 1.86%
73,282
+57
+0.1% +$5.36K
BUD icon
28
AB InBev
BUD
$156B
$6.45M 1.84%
60,696
+103
+0.2% +$12K
UPS icon
29
United Parcel Service
UPS
$96B
$5.93M 1.69%
60,089
-120
-0.2% -$11.8K
MDT icon
30
Medtronic
MDT
$108B
$5.56M 1.58%
83,060
+42,045
+103% +$3.1M
PX
31
DELISTED
Praxair Inc
PX
$5.52M 1.57%
54,160
+69
+0.1% +$7.61K
UNP icon
32
Union Pacific
UNP
$178B
$5.38M 1.53%
60,908
+63
+0.1% +$5.75K
ABBV icon
33
AbbVie
ABBV
$454B
$5.28M 1.5%
97,007
-47,560
-33% -$3.1M
ORCL icon
34
Oracle
ORCL
$345B
$5.17M 1.47%
143,291
-315
-0.2% -$12.1K
HBAN icon
35
Huntington Bancshares
HBAN
$34.7B
$5.1M 1.45%
481,545
+867
+0.2% +$9.67K
FMX icon
36
Fomento Económico Mexicano
FMX
$45B
$4.75M 1.35%
53,186
-149
-0.3% -$13.2K
IJH icon
37
iShares Core S&P Mid-Cap ETF
IJH
$123B
$4.48M 1.27%
163,865
-435
-0.3% -$12.6K
IBB icon
38
iShares Biotechnology ETF
IBB
$9.44B
$4.21M 1.2%
41,610
+90
+0.2% +$10.8K
VIG icon
39
Vanguard Dividend Appreciation ETF
VIG
$112B
$3.87M 1.1%
52,495
+207
+0.4% +$16K
ITOT icon
40
iShares Core S&P Total US Stock Market ETF
ITOT
$93.5B
$3.49M 0.99%
79,682
+128
+0.2% +$5.94K
V icon
41
Visa
V
$689B
$3.2M 0.91%
45,983
-2
-0% -$143
ABT icon
42
Abbott
ABT
$182B
$3.06M 0.87%
76,022
-137
-0.2% -$6.46K
SNCR
43
DELISTED
Synchronoss Technologies
SNCR
$2.82M 0.8%
9,558
-23
-0.2% -$8.92K
NVS icon
44
Novartis
NVS
$297B
$2.6M 0.74%
+31,619
New +$2.81M
RTX icon
45
RTX Corp
RTX
$294B
$1.37M 0.39%
24,483
-350
-1% -$21.5K
BMY icon
46
Bristol-Myers Squibb
BMY
$128B
$990K 0.28%
16,727
BIIB icon
47
Biogen
BIIB
$29.5B
$904K 0.26%
3,101
CVX icon
48
Chevron
CVX
$378B
$843K 0.24%
10,683
ADP icon
49
Automatic Data Processing
ADP
$102B
$832K 0.24%
10,356
INTC icon
50
Intel
INTC
$462B
$825K 0.23%
27,394
+6,875
+34% +$199K

Similar funds

J.M. Forbes & Co's Q3 2015 Portfolio in Review

As of Q3 2015, J.M. Forbes & Co held 107 positions worth $351M, down 5.4% from $371M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

J.M. Forbes & Co's Q3 2015 filing shows 3 new, 33 increased, 25 reduced and 6 closed positions. Its largest new stake was Novartis: 31,619 shares worth $2.6M. The largest sale was AbbVie, an estimated $3.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • J.M. Forbes & Co's largest Q3 2015 buy was Novartis: 31,619 shares worth $2.6M.
  • J.M. Forbes & Co added most to Medtronic in Q3 2015, an estimated $3.1M increase.
  • J.M. Forbes & Co's biggest Q3 2015 reduction was AbbVie, cutting an estimated $3.1M.
  • J.M. Forbes & Co fully exited ConocoPhillips in Q3 2015, selling an estimated $237K.
  • J.M. Forbes & Co's ten largest holdings make up 33% of its $351M portfolio in Q3 2015.
  • J.M. Forbes & Co opened 3 new positions and closed 6 in Q3 2015.
  • J.M. Forbes & Co's portfolio value fell 5.4% quarter-over-quarter to $351M.

Based on J.M. Forbes & Co's 13F filing for Q3 2015, filed 12 Nov 2015.